A Phase 1 Study of Intravitreous E10030 in Combination with Ranibizumab in Neovascular Age-Related Macular Degeneration. (Q53660955)

From Wikidata

Jump to navigation Jump to search

scientific article published on 20 October 2015

edit

Language	Label	Description	Also known as
English	A Phase 1 Study of Intravitreous E10030 in Combination with Ranibizumab in Neovascular Age-Related Macular Degeneration.	scientific article published on 20 October 2015

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26499921

retrieved

17 May 2018

reference URL

http://europepmc.org/abstract/MED/26499921

title

A Phase 1 Study of Intravitreous E10030 in Combination with Ranibizumab in Neovascular Age-Related Macular Degeneration. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26499921

retrieved

17 May 2018

reference URL

http://europepmc.org/abstract/MED/26499921

author name string

Glenn J Jaffe

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26499921

retrieved

17 May 2018

reference URL

http://europepmc.org/abstract/MED/26499921

Dean Eliott

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26499921

retrieved

17 May 2018

reference URL

http://europepmc.org/abstract/MED/26499921

John A Wells

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26499921

retrieved

17 May 2018

reference URL

http://europepmc.org/abstract/MED/26499921

Jonathan L Prenner

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26499921

retrieved

17 May 2018

reference URL

http://europepmc.org/abstract/MED/26499921

Andras Papp

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26499921

retrieved

17 May 2018

reference URL

http://europepmc.org/abstract/MED/26499921

Samir Patel

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26499921

retrieved

17 May 2018

reference URL

http://europepmc.org/abstract/MED/26499921

publication date

20 October 2015

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26499921

retrieved

17 May 2018

reference URL

http://europepmc.org/abstract/MED/26499921

published in

Ophthalmology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26499921

retrieved

17 May 2018

reference URL

http://europepmc.org/abstract/MED/26499921

volume

123

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26499921

retrieved

17 May 2018

reference URL

http://europepmc.org/abstract/MED/26499921

issue

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26499921

retrieved

17 May 2018

reference URL

http://europepmc.org/abstract/MED/26499921

page(s)

78-85

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26499921

retrieved

17 May 2018

reference URL

http://europepmc.org/abstract/MED/26499921

Identifiers

DOI

10.1016/J.OPHTHA.2015.09.004

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26499921

retrieved

17 May 2018

reference URL

http://europepmc.org/abstract/MED/26499921

PubMed publication ID

26499921

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26499921

retrieved

17 May 2018

reference URL

http://europepmc.org/abstract/MED/26499921

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53660955&oldid=2164199370"